Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SEPTIN4-AS1 (Septin 4 antisense RNA 1) is a long non-coding RNA gene located at cytogenetic region 17q22[6]. It is transcribed in the antisense orientation relative to the SEPTIN4 protein-coding gene. While the canonical function of SEPTIN4-AS1 is not currently annotated, antisense lncRNAs frequently modulate the expression or splicing of their associated sense genes (here, SEPTIN4), possibly affecting cytoskeletal organization, cell division, and apoptosis indirectly via regulation of SEPTIN4[2][4][6]. However, experimental evidence for specific functions, disease associations, or therapeutic relevance of SEPTIN4-AS1 is lacking.
Not applicable; no drugs directly targeting this molecule have been reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Septin 4 antisense RNA 1 (SEPTIN4-AS1).